Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis

Rhinology

Volumn 49, Issue 5, 2011, Pages 519-524

  Alobid, Isam ^a,d,e   Cardelus, Sara ^a   Benítez, Pedro ^c   Guilemany, José Maria ^a,d,e   Roca Ferrer, Jordi ^d   Picado, Cesar ^b,e   Bernal Sprekelsen, Manuel ^a   Mullol, Joaquim ^a,d,e  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital de Sant Joan Despi Moises Broggi   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Asthma; Chronic rhinosinusitis; Nasal polyposis; Olfaction; Smell loss

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; NOSE POLYP; RHINITIS; SINUSITIS; SMELLING DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; OLFACTION DISORDERS; RHINITIS; SINUSITIS;

EID: 84856562792     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino10.295     Document Type: Article

References (38)

1. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005; 60: 583-601.
2. 3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology. 2007; 45: 97-101.
3. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000; 16: 432-436.
4. Guilemany JM, Angrill J, Alobid I, et al. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient's quality of life. Allergy. 2009; 64: 1524-1529.
5. Ceylan E, Gencer M, San I. Nasal polyps and the severity of asthma. Respirology. 2007; 12: 272-276.
6. Benítez P, Alobid I, de Haro J, et al. A short course of oral pred-nisone followed by long term intranasal budesonide is an effective treatment of severe nasal polyps. Comparative study of various methods of assessment. Laryngoscope. 2006; 116: 770-775.
7. Alobid I, Benítez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life. Comparison between the effects of medical and surgical treatments. Allergy. 2005; 60: 452-458.
8. Alobid I, Benítez P, Bernal-Sprekelsen M, Guilemany JM, Picado C, Mullol J. The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res. 2005; 14: 789-793.
9. Alobid I, Bernal-Sprekelsen M, Mullol J. Chronic rhinosinusitis and nasal polyps. The role of generic and specific questionnaires on assessing its impact on patient s quality of life. Allergy. 2008; 63: 1267-1279.
10. Baroody F, Naclerio R. Allergic rhinitis. In: Getchell TV, Bartoshuk LM, Doty RL, Snow J, eds. Smell and Taste in Health and Disease. New York: Raven Press, 1991. p. 731-740.
11. Doty RL, Mishra A. Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope. 2001; 111: 409-423.
12. Guilemany JM, Angrill J, Alobid I, et al. United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiecta-sis. Allergy. 2009; 64: 790-797.
13. Guilemany JM, García-Piñero A, Alobid I, et al. Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope. 2009; 119: 233-238.
14. Wrobel BB, Leopold DA. Clinical assessment of patients with smell and taste disorders. Otolaryngol Clin North Am. 2004; 37: 1127-1142.
15. Cardesín A, Alobid I, Benítez P, et al. Barcelona Smell Test - 24 (BAST-24). Validation and smell characteristics in Spaniard healthy population. Rhinolgy. 2006; 44: 83-89.
16. Global Initiative for Asthma (GINA). National Asthma Education and Prevention Program: Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics. National Institutes of Health, National Heart, Lung and Blood Institute. NIH publication No. 02-3659, Maryland, USA, 2002; 210-218.
17. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg. 1997; 123: 595-600.
18. Lund VJ, Mackay I. Staging in rhinosinusitis. Rhinology. 1993; 31:183-184.
19. Hotchkiss WI. Influence of prednisone on nasal polyposis with anosmia. Ann Allergy. 1956; 24: 278-283.
20. Kondo H, Matsuda T, Hashiba M, Baba S. A study of the relationship between the T&T olfactometer and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol. 1998; 12: 353-358.
21. Litvack JR, Fong K, Mace J, James KE, Smith TL. Predictors of olfactory dysfunction in patients with chronic rhinosinusitis. Laryngoscope. 2008; 118: 2225-2230.
22. Vento SI, Simola M, Ertama LO, Malmberg CHO. Sense of smell in long- standing nasal polyposis. Am J Rhinol. 2001; 15: 159-163.
23. Cowart BJ, Flynn-Rodden K, McGeady SJ, Lowry LD. Hyposmia in allergic rhinitis. J Allergy Clin Immunol. 1993; 91: 747-751.
24. Rydzewski B, Pruszewicz A, Sulkowski WJ. Assessment of smell and taste in patients with allergic rhinitis. Acta Otolaryngol. 2000; 120: 323-326.
25. Landis BN, Lacroix JS. Olfactory function and nasal nitric oxide. Curr Opin Otolaryngol Head Neck Surg. 2009; 17: 18-22.
26. Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000; 110: 1071-1077.
27. Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic rhinosi-nusitis. Otolaryngol Head Neck Surg. 2009; 141: 454-461.
28. Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001; 107: 73-80.
29. Bavbek S, Celik G, Ediger D, et al. Severity and associated risk factors in adult asthma patients in Turkey. Ann Allergy Asthma Immunol. 2000; 85: 134-139.
30. Ehnhage A, Olsson P, Kölbeck KG, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy. 2009; 64: 762-769.
31. Apter AJ, Gent JF, Rank ME. Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis. Arch Otolaryngol Head Neck Surg. 1999; 125: 1005-1010.
32. Staik niene J, Vaitkus S, Japertiene LM, Ryskiene S. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. Medicina (Kaunas). 2008; 44: 257-265.
33. Wabnitz DA, Nair S, Wormald PJ. Correlation between preop-erative symptom scores, quality-of-life questionnaires, and staging with computed tomography in patients with chronic rhinosinusitis. Am J Rhinol. 2005; 19: 91-96.
34. Stewart MG, Donovan DT, Parke RB, Bautista MH. Does the severity of sinus computed tomography findings predict outcome in chronic sinusitis? Otolaryngol Head Neck Surg. 2000; 123: 81-84.
35. Alobid I, Benítez P, Valero A, et al. The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis. Otolaryngol Head Neck Surg. 2006; 134: 609-612.
36. Krouse JH. Computed tomography stage, allergy testing, and quality of life in patients with sinusitis. Otolaryngol Head Neck Surg. 2000; 123: 389-392.
37. Bhattacharyya N. Radiographic stage fails to predict symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2006; 116: 18-22.
38. Konstantinidis I, Triaridis S, Printza A, Vital V, Ferekidis E, Constantinidis J. Olfactory dysfunction in nasal polypo-sis: correlation with computed tomography findings. ORL J Otorhinolaryngol Relat Spec. 2007; 69: 226-232.